Bilal A Tahir1,2,3, Paul JC Hughes2, Jack Atkinson2,3, Isaac Jadav1, Joshua R Astley1,2, Stephen D Robinson1,4, Alberto Biancardi2, Helen Marshall2, Kerry A Hart1,5, James A Swinscoe1, Rob H Ireland1,2, Matthew Q Hatton1,4, and Jim M Wild2,3
1Department of Oncology and Metabolism, The University of Sheffield, Sheffield, United Kingdom, 2POLARIS, Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom, 3Insigneo Institute for in silico medicine, The University of Sheffield, Sheffield, United Kingdom, 4Clinical Oncology, Weston Park Cancer Centre, Sheffield, United Kingdom, 5Radiotherapy Physics, Weston Park Cancer Centre, Sheffield, United Kingdom
Synopsis
Radiotherapy plays a central role
in the management of lung cancer. However, despite advances, survival of lung
cancer patients undergoing radiotherapy remains poor, partly attributable to
the incidence of radiation-induced lung injury, which is exacerbated in
patients with poor pulmonary function. Both ventilation and perfusion
information are vital to providing a complete picture of pulmonary function,
ideally in a regional fashion. Here, we develop and apply an image acquisition
and analysis pipeline to assess dose-related changes in regional lung function
as derived from hyperpolarized gas ventilation and dynamic contrast-enhanced
perfusion MRI in lung cancer patients receiving a course of radiotherapy.
Introduction
Radiotherapy
(RT) plays a central role in the management of non-small cell lung cancer
(NSCLC). Despite advances in RT, including the development of stereotactic
ablative RT (SABR), survival outcomes remain disappointing.
One of the factors underlying
poor survival is radiation-induced lung injury, which is exacerbated by poorer
functional pulmonary reserve pre-RT1. The pre-RT lung function of
NSCLC patients is currently assessed by conventional pulmonary function tests
(PFTs). However, PFTs are relatively crude as they provide global, whole-lung
measures and have limited sensitivity to early changes2.
As the primary function of the
lungs is gas exchange, both ventilation (V) and perfusion (Q) information are
vital to providing a complete picture of lung function, preferably in a
regional fashion. Despite poor spatial and temporal resolution, regional lung
function has traditionally been assessed by radionuclide scintigraphy or
single-photon emission computed tomography3. Alternatively, MRI can
provide high-resolution images of regional lung function as assessed by dynamic
contrast-enhanced (DCE) perfusion proton (1H) MRI and hyperpolarized
gas ventilation MRI4.
Here, we develop and apply an image acquisition
and analysis pipeline to assess dose-related changes in regional lung function
as derived from MRI V/Q in NSCLC patients receiving a course of RT.Methods
Patient and imaging data
12 NSCLC patients receiving RT underwent
pre-RT free-breathing CT as standard-of-care and inspiratory breath-hold CT at
functional residual capacity (FRC)+1L. Helium-3 (3He) (3D SSFP) and 1H-MRI
(3D SPGR) were acquired in the same breath and inflation state as inspiratory
CT5 following inhalation of 200ml hyperpolarized 3He and
800ml N2. Imaging was performed at 1.5T (GE HDx) using a 3He
transmit-receive vest coil (CMRS). Patients were repositioned in an 8-channel
cardiac coil with DCE-MRI acquired using a 3D SPGR sequence and parallel imaging6.
All MRI scans were repeated 3-4 months post-RT.
Image registration
Images were segmented using
previously described methods7,8. Free-breathing CT, planned dose
distribution and RT contours were deformably registered to inspiratory CT. Pre-RT
inspiratory CT, the warped dose distribution and RT contours, post-RT 3He-MRI
and pre- and post-RT DCE-MRI were registered to the spatial domain of pre-RT 3He-MRI9.
The registration workflow is shown in Figure 1.
Dosimetric and image analysis
A threshold of ≥20Gy
was applied to the warped dose distribution minus the gross tumour volume. This
threshold was selected as it has been validated as a predictive marker for radiation
pneumonitis10. All lung function metrics described below were
computed in this dose region.
Ventilation and perfusion defect
percentages (VDP, QDP, respectively) were computed from the ratios of the
ventilated and perfused lung segmentations over the pre-RT 1H-MRI
thoracic cavity volume. The spatial overlap of ventilated and perfused defects
was computed via the Dice similarity coefficient (DSC) to assess global V/Q
matching (DSC(V/Q)). Fractional ventilation (FV)11, pulmonary blood
volume (PBV), pulmonary blood flow (PBF) and mean transit time (MTT)12
were computed as previously described. The V/Q ratio (FV/PBV) was used as a
surrogate of gas exchange13.
Statistical analysis
Wilcoxon signed-rank tests were
used to assess differences in imaging biomarkers pre- and post-RT.Results
9 of the 12 patients underwent all
imaging tests required to be included in this study. Figure 2 shows an example
of the workflow shown in Figure 1 applied successfully to a representative
patient in the study. Changes in VDP and QDP can be observed, particularly in
the vicinity of the tumor, which receives the highest doses of radiation.
Figure 3 summarizes the VDP, QDP
and DSC(V/Q) results for all patients pre- and post-RT. Statistically
significant differences between these metrics before and after RT were only
observed for DSC(V/Q).
Figure 4 summarizes the results for the V/Q
metrics. Although PBF was the only metric to exhibit a statistically significant difference
between pre- and post-RT, trends towards significance were observed for FV and
PBV.Discussion
No hitherto published study in
humans has investigated dose-related changes in MRI V/Q. Our acquisition and
analysis pipeline allowed these investigations to be conducted and showed
significant changes in the DSC(V/Q), indicating that combined V/Q may be
effective in detecting radiation-induced lung injury.
The significant changes in vascular
response to radiation as observed by pre- and post-RT PBF measurements are in
line with preclinical studies in irradiated rats14-15; radiation
induces endothelial injury which exposes basement membrane, resulting in
platelet adhesion and vascular obstruction, thus limiting blood flow15.
Although no statistically significant differences were observed in other
regional lung function biomarkers pre- and post-RT, this is likely attributable
to the relatively small sample size and range of pre-existing pulmonary functional
reserve of the NSCLC patients in this study. Moreover, the dose threshold of ≥20Gy
selected in this study may have masked differences in higher dose regions.
Whilst there is a strong evidential basis for this threshold, a dose-binning
approach may be more appropriate. Further work will investigate stratifying
patients according to pre-RT lung function and determining if regional lung
function changes are associated with low, moderate and high doses.Conclusion
Quantitative analysis
of dose-related changes in MRI V/Q-derived biomarkers is feasible using a
dedicated acquisition and analysis protocol. Significant dose-related reduction
in the overlap of ventilation and perfusion post-RT indicates that MRI V/Q may
play a role in detecting radiation-induced lung injury in patients undergoing
thoracic RT.Acknowledgements
This work was
supported by Yorkshire Cancer Research, Sheffield Hospitals Charity,
Weston Park Cancer Charity, National Institute of Health Research and
the Medical Research Council.References
1.
Robnett TJ, Machtay M,
Vines EF, et al. Factors predicting severe radiation pneumonitis in patients
receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys.
2000;48:89-94.
2.
Que C, Cullinan P, Geddes
D. Improving rate of decline of FEV1 in young adults with cystic fibrosis.
Thorax. 2006;61:155-7.
3.
Marks LB, Spencer DP,
Bentel GC, et al. The utility of SPECT lung perfusion scans in minimizing and
assessing the physiologic consequences of thoracic irradiation. Int J Radiat
Oncol Biol Phys. 1993;26(4):659-68.
4.
Ireland RH, Din OS, Swinscoe
JA, et al. Detection of radiation-induced lung injury in non-small cell lung
cancer patients using hyperpolarized helium-3 magnetic resonance imaging. Radiother
Oncol. 2010;97(2):244-8.
5.
Tahir BA, Hughes PJC,
Robinson SD, et al. Spatial comparison
of CT-based surrogates of lung ventilation with hyperpolarized helium-3 and xenon-129
gas MRI in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys.
2018;102(4):1276-86.
6.
Johns CS, Swift AJ, Rajaram
S, et al. Lung perfusion: MRI vs. SPECT for screening in suspected chronic
thromboembolic pulmonary hypertension. 2017;46(6):1693-7.
7.
Hughes PJC, Horn FC,
Collier GJ, et al. Spatial fuzzy c-means thresholding for semiautomated
calculation of percentage lung ventilated volume from hyperpolarized gas and 1H
MRI. J Magn Reson Imaging. 2018;47(3):640-6.
8.
Schiwek M, Triphan SMF,
Biederer J, et al. Quantification of pulmonary perfusion abnormalities using
DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. Eur
Radiol. 2021. DOI: 10.1007/s00330-021-08229-6
9.
Tahir BA, Swift AJ,
Marshall H, et al. A method for quantitative analysis of regional lung
ventilation using deformable image registration of CT and hybrid hyperpolarized
gas/1H MRI. Phys Med Biol. 2014;59(23):7267-77.
10.
Palma DA, Senan S, Tsujino
K, et al. Predicting radiation pneumonitis after chemoradiation therapy for
lung cancer: an international individual patient data meta-analysis. Int J
Radiat Oncol Biol Phys. 2013;85(2):444-50.
11.
Tzeng YS, Lutchen K and
Albert M. The difference in ventilation heterogeneity between asthmatic and
healthy subjects quantified using hyperpolarized 3He MRI. J Appl
Physiol. 2009;106(3):813-22.
12.
Sourbron SP and Buckley DL.
Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013:26(8):1004-27.
13.
Hughes PJC, Tahir BA, Horn
FC, et al. Quantitative ventilation-perfusion imaging using co-registered
hyperpolarized gas and contrast enhanced 1H perfusion MRI. ISMRM
2017.
14.
Peterson LM, Evans ML, Graham
MM, et al. Vascular response to radiation injury in the rat lung. Radiation
Research. 1992:129(2):139-48.
15.
Peterson LM, Evans ML,
Thomas KL, et al. Vascular response to fractionated irradiation in the rat lung.
Radiation Research. 1992:132(2):224-6.